Methodologic approaches to evaluating new highly sensitive diagnostic tests: avoiding overdiagnosis
Open Access
- 4 July 2016
- journal article
- review article
- Published by CMA Impact Inc. in Canadian Medical Association Journal
- Vol. 189 (2) , E64-E68
Abstract
A major contributor to the rising problem of overdiagnosis, with the subsequent risk of overtreatment, is the development of highly sensitive diagnostic technologies that challenge and sometimes expand existing disease definitions. Whereas such technologies might help to identify new or milderKeywords
This publication has 19 references indexed in Scilit:
- From accuracy to patient outcome and cost-effectiveness evaluations of diagnostic tests and biomarkers: an exemplary modelling studyBMC Medical Research Methodology, 2013
- A capture-recapture analysis demonstrated that randomized controlled trials evaluating the impact of diagnostic tests on patient outcomes are rareJournal of Clinical Epidemiology, 2012
- LINKING THE EVIDENCE: INTERMEDIATE OUTCOMES IN MEDICAL TEST ASSESSMENTSInternational Journal of Technology Assessment in Health Care, 2012
- Target practice: choosing target conditions for test accuracy studies that are relevant to clinical practiceBMJ, 2011
- Decision analysis to complete diagnostic research by closing the gap between test characteristics and cost-effectivenessJournal of Clinical Epidemiology, 2009
- Overdiagnosis in publicly organised mammography screening programmes: systematic review of incidence trendsBMJ, 2009
- Various randomized designs can be used to evaluate medical testsJournal of Clinical Epidemiology, 2009
- Ramifications of screening for breast cancer: Overdiagnosis in the Malmö trial was considerably underestimatedBMJ, 2006
- Assessment of the accuracy of diagnostic tests: the cross-sectional studyJournal of Clinical Epidemiology, 2003
- Randomised comparisons of medical tests: sometimes invalid, not always efficientThe Lancet, 2000